Loading provider…
Loading provider…
Neurology Physician in Phoenix, AZ
NPI: 1023018223Primary Practice Location
21st Century Neurology
2601 N 3rd St, Phoenix, AZ
Primary Employer
21st Century Neurology
21stcenturyneurology.com
HQ Phone
Get M.D. Stephen's Phone Numberphone_androidMobile
Get M.D. Stephen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAZ State Medical License
AZ State Medical License
1992 - 2026
MD State Medical License
1994 - 1998

National Board of Physicians and Surgeons
Neurology
Stony Brook Medicine/University Hospital
Internship • Internal Medicine
1990 - 1991
Barrow Neurological Institute at St Joseph's Hospital and Medical Center
Residency • Neurology
1991 - 1994
Albany Medical College
amc.edu
Medical School
Until 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 299 | 571 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 128 | 176 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 49 | 49 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 42 | 47 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 23 | 23 |
Prevalence of tremor and Parkinson''s disease.
Authors: Khatter, A S, Kurth, M C, Brewer, M A, Crinnian, C T, Drazkowski, J F, Flitman, S S, Imke, S, Spector, S A, Wood, K L, Lieberman, A N
Journal: Parkinsonism Relat Disord
PET imaging of maze processing
Authors: Flitman, S, O'Grady, J, Cooper, V, Grafman, J
Journal: Neuropsychologia
Occipital Nerve Blocks: When and What to Inject?
Authors: Tobin, Joshua, Flitman, Stephen
Journal: Headache
Publication Date: 2009-08-06
Lead Sponsor: Athira Pharma
Intervention / Treatment: DRUG: Placebo, DRUG: ATH-1017
Lead Sponsor: Alzheon Inc.
Intervention / Treatment: DRUG: Experimental: ALZ-801
Lead Sponsor: Cassava Sciences, Inc.
Collaborators: Premier Research Group plc
Intervention / Treatment: DRUG: Placebo, DRUG: Simufilam